Table 5 The categorization of severity among patients with FD, IBS, and FD-IBS overlap before and after therapy with the combination of RAF of Abs to S 100, Abs to TNF-α and Abs to H
Group | Severity category | ||||||
|---|---|---|---|---|---|---|---|
Healthy | Borderline ill | Mildly ill | Moderately ill | Markedly ill | Severely ill | ||
FD N = 2404 | Before therapy n (%) | 0 (0.0) | 161 (6.69) | 778 (32.36) | 740 (30.78) | 431 (17.92) | 294 (12.22) |
After 12 weeks of therapy, n (%) | 537(22.33) | 1339 (55.69) | 406 (16.88) | 99 (4.11%) | 17 (0.70) | 6 (0.24) | |
IBS N=5909 | Before therapy n (%) | 0 (0.0) | 214 (3.62) | 1911 (32.34) | 2113 (35.75) | 1036 (17.53) | 635 (10.74) |
After 12 weeks of therapy, n (%) | 1237 (20.93) | 3044 (51.51) | 1304 (22.06) | 267 (4.51) | 43 (0.72) | 14 (0.23) | |
FD-IBS overlap N = 941 | Before therapy n (%) | 0 (0.0) | 8 (0.85) | 133 (14.13) | 383 (40.70) | 241(25.61) | 176(18.70) |
After 12 weeks of therapy, n (%) | 156 (16.57) | 488 (51.85) | 205 (21.78) | 69 (7.33) | 18 (1.91) | 5(0.53) | |